---

Brought to you by RivalSense - an AI tool for monitoring any company.

RivalSense tracks the most important product launches, fundraising news, partnerships, hiring activities, pricing changes, tech news, vendors, corporate filings, media mentions, and other developments of companies you're following 💡

---

Roche

🌎 roche.com

Roche is a global pioneer in pharmaceuticals and diagnostics, founded in 1896 in Basel, Switzerland. The company focuses on advancing science to improve people's lives, with a strong emphasis on personalized healthcare. Roche is the world's largest biotech company, known for its innovative medicines in oncology, immunology, infectious diseases, and diagnostics. The company aims to improve patient access to medical innovations and has been recognized for its sustainability efforts in the pharmaceuticals and biotechnology industry.

---

Roche - Latest News and Updates

• The FDA accepted Roche's Gazyva/Gazyvaro for lupus nephritis review after the phase III REGENCY trial showed significant improvement in complete renal response.
• Genentech, part of Roche, received US FDA approval for TNKase to treat acute ischaemic stroke in adults.
• The CHMP recommends Roche's Columvi® (glofitamab) for approval in Europe for patients with relapsed or refractory diffuse large B-cell lymphoma.
• Roche is collaborating with Recursion and Genentech on neuroscience and GI oncology projects.
• Roche announced that the CHMP recommended EU approval for their bispecific antibody combination for aggressive lymphoma treatment.

• Victoria Valton has joined Roche as Divisional Change Lead, Roche Diagnostics in the United States, previously holding a position at Roche.
• Roche is currently hiring for the position of Squad Lead (Disease Area Business Lead) in Australia.
• Bergur Stefansson has joined Roche as Principal Medical Director, Disease Expert, CVRM in the Basel Metropolitan Area, previously holding a position at another company.
• Roche Pharma CEO Teresa Graham shared insights at the Longwood Healthcare Leaders event on March 4.
• Xolair from Roche outperforms oral immunotherapy in food allergy trials, indicating a shift in the $8 billion allergy market.

---

Sign up to receive regular updates

If you liked the insights, consider following your own companies of interest. Receive weekly insights directly to your inbox using RivalSense.